Linguistic validation is the process of translating a clinical outcome assessment (COA) — whether a PRO, ClinRO, ObsRO or PerfO instrument — so that it measures the same concept in every language and target population. TranslationsInLondon, a London-based ITI Corporate Member agency, runs linguistic validation projects for pharmaceutical companies, CROs and instrument developers.
Regulators such as the FDA and EMA expect patient-reported data from multinational trials to be comparable across countries. A questionnaire that is translated accurately but reads differently to patients can produce unreliable data. Linguistic validation provides the evidence that each translation is understood and relevant in its target population, supporting content validity and protecting the instrument’s psychometric integrity.
Linguistic validation checks both the language and the patient’s understanding, following the ISPOR Principles of Good Practice for the translation and cultural adaptation of PRO measures.
We review the instrument, agree concept definitions with the developer and set up the project.
Two qualified native-speaking translators translate the questionnaire independently.
A third linguist merges the two versions into one, resolving differences.
A translator who has not seen the original translates the reconciled version back into the source language.
The back translation is compared with the original and the target text is revised.
For multi-language projects, translations are compared to keep concepts consistent.
The translation is tested in interviews with patients (and caregivers, where relevant) from the target population in each country, confirming that items, instructions and response options are understood as intended.
Patient feedback is analysed and the translation is finalised.
The final version is proofread, and a report documents every step and decision.
The final, proofread translation of your instrument.
Full translation history and the rationale for every change, ready for inclusion in your regulatory submission.
A summary of patient interviews and how feedback was applied.
Already have a translation? We can run cognitive debriefing as a standalone service, quoted as a fixed package per country covering participant recruitment, interviewing, transcription, analysis and reporting. The deliverable is a cognitive debriefing report.
Standard translation produces an accurate text. Linguistic validation adds back translation, cross-checking and patient testing to show that the translated questionnaire is conceptually equivalent to the original.
Industry practice is usually five to eight participants per language and country, depending on the instrument and the sponsor’s requirements. Samples should be fit for purpose, with leaner designs for rare-disease and paediatric studies. Our standard package covers 5 participants per country.
Yes. When an instrument is delivered on a tablet, phone or web platform, the translated screens need the same care as a paper version. Moving a paper questionnaire to eCOA can change how patients read and answer items, so translated versions should be checked to make sure they remain equivalent.
Our process follows the ISPOR Principles of Good Practice for the translation and cultural adaptation of PRO measures.
Tell us about your instrument and target countries. Read more about our linguistic validation services.